hyperhomocysteinemia is also associated with a higher risk of venous thrombosis to which other coagulation disorders, such as factor v leiden, could contribute. hyperhomocysteinemia can be due to genetic defects in the enzymes that control homocysteine metabolism, and also to other factors, mainly ...
Factor V LeidenProthrombin G20210APAI-IHyperhomocisteinemiaFactor VIIIAntiphospholipid antibodiesWe aimed to determine the risk factors of thromboembolic disease in young patients and to study the clinical characteristics according to the etiology A prospective study of 100 patients under 50 years who ...
Antithrombin and protein C were de- termined by functional methods, as well as free fraction of protein S, resistance to activated pro- tein C, factor V Leiden R506Q mutation, pro- thrombin G20210A mutation, homocysteine and antiphospholipid antibodies: lupus and anticar- diolipin antibodies ...
In addition to the genetic variants currently used in clinical assessment of hereditary thrombophilia (e.g., Factor V Leiden, prothrombin mutation) there are other more recently discovered common gene variants that contribute to VTE risk15,16,17. However, even when these are also incorporated into...
Herrera R, D iaz E, P erez Aguilar R y col: Estado protrombotico en estadios tempranos de la enfermedad de Chagas cronica. Rev Esp Cardiol 2003; 56: 377-382.Herrera RN, Diaz E, Perez R, Chain S, Sant-Yacumo R, Rodriguez E, et al. Estado protrombotico en estadios tempranos...